Kunbo Medical-B (02216.HK) announced its interim performance as of the end of June this year, with revenue of $3.704 million (same below), a 29.2% decrease compared to the previous year. The loss narrowed to $7.943 million, compared to a loss of $14.731 million in the same period last year; loss per share of 2 cents. No dividend will be paid.
《業績》堃博醫療(02216.HK)半年虧損收窄至794.3萬美元
Performance: Kunbo Medical (02216.HK) narrowed its half-year loss to 7.943 million US dollars.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated